Navigation Links
Panetta Statement on Passing of Duane Roth
Date:8/3/2013

SAN DIEGO, Aug. 4, 2013 /PRNewswire/ -- Joe Panetta, president and CEO of BIOCOM, released the following statement upon news of the passing of Duane Roth, President and CEO of CONNECT:

"I speak for the BIOCOM board, staff, and the entire BIOCOM family in saying the life science industry has lost one of its most devoted champions.  Duane's passion for the industry first as a company executive (with Alliance Pharmaceutical) and later as CONNECT's President and CEO was unwavering.  His contributions to San Diego are not limited to the life science industry, and his loss will be felt throughout our community."

(Logo: http://photos.prnewswire.com/prnh/20130228/LA69104LOGO)

"Personally, I will deeply miss Duane as a friend, colleague, and confidant.  Our lives were intertwined not only professionally but socially and casually as well.  Karin and I extend our deepest sympathies to Renee and the entire Roth family."

Duane Roth was a founding member of the BIOCOM Board of Directors and is the only person to have served two terms as BIOCOM board chair, in 1996-97 and 2004-05.  In 2010, Roth was given the highest honor BIOCOM can bestow on a board member, that of Life Director, a position reserved only to those who have distinguished themselves in service at the highest levels to BIOCOM and the Southern California life science community.


'/>"/>
SOURCE BIOCOM
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Life Technologies Announces Filing of Definitive Proxy Statement
2. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
3. Vermillions OVA1 Receives New Statement by Society of Gynecologic Oncology
4. Royalty Pharma Statement Regarding Elan Law Suits
5. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
6. CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Vestiage Announces Filing of Disclosure Statement with Exchange
9. Royalty Pharma Statement Regarding Elan Proposal
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Statement by Life Technologies Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... BELLINGHAM, Washington, USA (PRWEB) , ... December 02, ... ... the role of innovative U.S.-owned and -operated small businesses in federally funded research ... SPIE, the international society for optics and photonics . , As part ...
(Date:12/2/2016)... 2, 2016 More than $4.3 million was raised ... ( DHMD ). The gala was held at the American ... City and honored Alan Alda and ... health and medicine and the public understanding of science. Since ... the event has raised $40 million for the Laboratory,s research ...
(Date:12/2/2016)... ... ... ACEA Biosciences, Inc. announced today that it will be presenting updated efficacy ... Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. , ... AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M resistance ...
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
Breaking Biology Technology:
(Date:11/19/2016)... DALLAS , Nov. 18, 2016 Securus ... technology solutions for public safety, investigation, corrections and monitoring, ... a smaller competitor, ICSolutions, to have an independent technology ... set, the most modern high tech/sophisticated telephone calling platform, ... tell customers that they do most of what we ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... offering. The report forecasts the ... at a CAGR of 12.28% during the period 2016-2020. ... analysis with inputs from industry experts. The report covers the market ... also includes a discussion of the key vendors operating in this ...
Breaking Biology News(10 mins):